International digital therapeutics leader Sidekick Health has raised $55 million in a Series B funding round led by London-based venture capital firm Novator Ventures.
Wellington Partners, Asabys Partners, and Frumtak Ventures also participated in the round along with a US-based strategic investor that will be revealed at a later stage.
Novator Ventures general partner and founder Birgir Mar Ragnarsson joins Sidekick’s board of directors in conjunction with the closing of the Series B financing.
